Replies to post #544727 on NorthWest Biotherapeutics Inc (NWBO)

[hoffmann6383]

Reimbursement for the cost of buying DCVax-L (to patients, hospitals, or anyone else) by the UK's National Health Service (NHS) is a whole other kettle of fish that can't even begin until after DCVax-L has received marketing authorization by the MHRA.

Sometimes this process can proceed concurrently with the approval of DCVax-L.